Syndax Pharmaceuticals Inc

NASDAQ:SNDX   1:32:18 PM EDT
15.08
+0.32 (+2.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.30B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$49.05 Million
Adjusted EPS-$0.72
See more estimates
10-Day MA$15.51
50-Day MA$13.25
200-Day MA$12.81
See more pivots

Syndax Pharmaceuticals Inc Stock, NASDAQ:SNDX

730 Third Avenue, floor 9, New York, New York 10017
United States of America
Phone: +1.781.419.1400
Number of Employees: 270

Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.